| Detected | Trial | Change |
|---|---|---|
| 2026-06-09 | NCT07566156 Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy… |
Trial sites expanded: 1 -> 9 locations |
| 2026-05-30 | NCT06388720 The Clinical Effectiveness and Safety of Intravesical Mitomycin-C and Gemcitabine… |
date change Completion pushed: 2027-12-31 -> 2028-12-31 |
| 2026-05-23 | NCT04216290 A Study of Chemotherapy and Radiation Therapy Compared to Chemotherapy and Radiation… |
Enrollment reduced: 95 -> 11 participants |
| 2026-05-23 | NCT04216290 A Study of Chemotherapy and Radiation Therapy Compared to Chemotherapy and Radiation… |
date change Primary completion moved earlier: 2026-06-30 -> 2026-02-04 |
| 2026-05-23 | NCT04216290 A Study of Chemotherapy and Radiation Therapy Compared to Chemotherapy and Radiation… |
date change Completion pushed: 2026-06-30 -> 2027-05-19 |
| 2026-05-14 | NCT06770582 Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy… |
Trial sites expanded: 125 -> 128 locations |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06513065 | Study to Evaluate the Non-inferiority of Low-dose HIPEC Versus High-dose HIPEC in the… | Pseudomyxoma Peritonei | Recruiting |
| NCT07097142 | Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients… | Muscle Invasive Bladder Urothelial Carcinoma | Recruiting |
| NCT06319820 | A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in… | Non-Muscle Invasive Bladder Neoplasms | Recruiting |
| NCT06919965 | A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants… | Non-Muscle Invasive Bladder Neoplasms | Recruiting |
| NCT06783491 | Efficacy of the Use of Neoadjuvant With/Without Hyperthermic Intraperitoneal Chemotherapy… | Locally Advanced Colorectal Cancer | Recruiting |
| NCT07566156 | Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy… | Urothelial Cancer | Recruiting |
| NCT04241185 | Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Chemoradiotherapy… | Urinary Bladder Neoplasms | Active, Not Recruiting |
| NCT03775265 | Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle… | Bladder Urothelial Carcinoma | Active, Not Recruiting |
| NCT06211764 | A Study of TAR-200 Versus Intravesical Chemotherapy in Participants With Recurrent… | Non-Muscle Invasive Bladder Neoplasms | Active, Not Recruiting |
| Phase 2 | |||
| NCT05672108 | Phase II Trial of Lung Chemoemobolization | Lung Non-Small Cell Carcinoma | Recruiting |
| NCT06388720 | The Clinical Effectiveness and Safety of Intravesical Mitomycin-C and Gemcitabine… | Bladder Cancer | Recruiting |
| NCT04107077 | Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy… | Gastric Cancer | Recruiting |
| NCT06770582 | Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy… | Non-Muscle Invasive Bladder Urothelial Carcinoma | Recruiting |
| NCT07475286 | Combined Systemic and Intraperitoneal Chemotherapy for Synchronous Gastric and/or… | Synchronous Gastric Peritoneal Carcinomatosis | Not Yet Recruiting |
| NCT04166318 | Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE… | Anal Basaloid Carcinoma | Active, Not Recruiting |
| NCT04929028 | Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer | AIDS-Related Anal Carcinoma | Active, Not Recruiting |
| NCT04216290 | A Study of Chemotherapy and Radiation Therapy Compared to Chemotherapy and Radiation… | Bladder Urothelial Carcinoma | Active, Not Recruiting |
| Phase 1/2 | |||
| NCT06704191 | In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial | Non-Muscle Invasive Bladder Carcinoma | Recruiting |
| NCT07579195 | Consolidative Therapy After EV + Pembrolizumab in Muscle Invasive Bladder Cancer… | Muscle Invasive Bladder Carcinoma | Not Yet Recruiting |
| Phase 1 | |||
| NCT04847063 | Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of… | Peritoneal Mesothelioma | Recruiting |
| NCT07487168 | Safety and Efficacy of PIPAC Using Single Agent Mitomycin in Solid Tumors | Peritoneal Carcinomatosis | Not Yet Recruiting |
| Not specified | |||
| NCT05838391 | Adaptive Radiation in Anal Cancer | Anal Squamous Cell Carcinoma | Recruiting |